16 October 2023

Champalimaud Foundation scientists create health data cloud infrastructure for research for the first time in Portugal

A novel infrastructure for storing, consulting and analysing medical data will be presented at the Open Day of the Champalimaud Foundation (FC) Breast Unit, which is taking place today, October 16. It was created by the Unit's Digital Surgery Lab, a multidisciplinary team led by surgeon Pedro Gouveia, in partnership with the telecommunications company Altice and the Portuguese company BMD Software.

Artificial Intelligence: Paradigm Shift for Breast Cancer Patients

The Breast Unit of the Champalimaud Clinical Center organizes, for the 5th year, the Breast Unit Open Day, this year dedicated to Artificial Intelligence and its transformative impact on breast cancer patients.

28 September 2023

Check Up #18 - Side effects of cancer treatments. Can we classify them?

A side-effect “is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant”. 

Challenging Malignant Melanoma

Malignant melanoma is a highly aggressive form of skin cancer that is on the rise. However, recent breakthrough research has introduced new targeted therapies and immunotherapies for melanoma treatment, transforming the approach to treating melanoma and offering hope to patients with limited alternatives.

08 September 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 7

World Physiotherapy Day has been celebrated since 1996, but 8 September was chosen as the date because this was when World Physiotherapy (a global collective of Physiotherapists) was founded in 1951.

The day marks the unity and solidarity of the global physiotherapy community. It is also an opportunity to recognise the work that physiotherapists do for their patients and community. 

05 September 2023

European Research Council awards three ERC Starting Grants to Life Sciences in Portugal

The distinguished recipients from Portugal are Giulia Ghedini and Ilana Gabanyi from the Gulbenkian Science Institute (IGC) and Carlos Minutti of the Champalimaud Foundation. The principal investigators will be granted between €1.5-1.9M each to develop their research proposals over the next five years.

31 August 2023

Check Up #17 - What distinguishes cancer epidemiology and aetiology and why is each important?

But this doesn’t mean these two areas are totally distinct. In fact, epidemiology also deals with the causes of disease. But while epidemiology involves the study of determinants and distribution of disease, aetiology attempts to confirm the causes.

23 Apr. 2026

Assistentes Operacionais com experiência em Bloco Operatório

Clinical Centre
Application Starts: 28 Aug. 2023

A Fundação Champalimaud pretende recrutar Assistentes Operacionais com experiência em Bloco Operatório.

Requisitos

- Experiência mínima 1 ano;
- Conhecimentos de informática na ótica do utilizador;
- Capacidade de trabalho em equipa e bom relacionamento interpessoal.

Oferece

- Remuneração adequada à função desempenhada;
- Seguro de Saúde.

24 August 2023

Ninety per cent of the cancers occur after the age of 50

Interview with António Parreira, Clinical Director of the Champalimaud Clinical Centre

Has there been an increase in the number of cancer cases? What is the reason for this?

We know that there has indeed been an increase. The question is to try to understand how we can, not only understand this phenomenon, but also, somehow, minimise its effects.

This phenomenon has to do with ageing. The development of cancers is one of the very direct consequences of ageing.

10 August 2023

Check Up #16 - What is cancer chemoprevention and when does it apply?

That said, this definition has been widening throughout the years to include potential chemopreventive substances that are not necessarily drugs. So-called “nutraceuticals”, such as dietary fiber, prebiotics, probiotics, polyunsaturated fatty acids, antioxidants (such as vitamins) and different types of herbal or natural foods (dietary supplements) are also being studied for cancer chemoprevention. However, to date, the efficacy of these substances has not been confirmed.

Subscribe to Cancer
Loading
Please wait...